Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 656 across all filing types
Latest filing 2008-09-09 Regulatory Filings
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2008
Regulatory Filings Classification · 95% confidence The document is a press release dated September 9, 2008, announcing a significant operational milestone: the first international use of the STEEN Solution™ technology in a lung transplantation outside Sweden. It details product progress, regulatory steps (approvals in Europe, Australia, and planned studies for US/Canada), and includes quotes from the CEO. This type of announcement, focusing on a specific business development, product breakthrough, or regulatory update that is not a standard periodic financial report (like 10-K or IR), best fits the general category for corporate news releases that don't fit elsewhere. Since it is not a formal financial report, earnings release, or management discussion, and it is not explicitly about director dealings, capital changes, or dividends, the most appropriate classification is the general 'Regulatory Filings' (RNS) as a catch-all for significant, non-standard corporate announcements, or potentially 'LTR' if viewed as a major operational development, but RNS is safer for general press releases. Given the options, and that it is a general corporate announcement about a product breakthrough, RNS (Regulatory Filings) is the best fit as a non-standard filing.
2008-09-09 English
Regulatory Filings 2008
Regulatory Filings Classification · 95% confidence The document is a press release dated September 9, 2008, announcing a significant operational milestone: the first international use of the STEEN Solution™ lung transplantation technique outside of Sweden. It details a clinical breakthrough, mentions regulatory progress (approvals in Europe/Australia, pending study in Canada/US), and provides company background. This type of announcement, focusing on a specific operational or scientific development rather than comprehensive financial results (10-K, IR, ER) or mandatory shareholder voting materials (DEF 14A, DVA), fits best under a general regulatory announcement or news release category. Since it is a specific, non-financial, non-governance announcement of a major event, and does not fit the definitions for ER, IR, LTR, or CAP, it is classified as a general Regulatory Filing (RNS) as it serves as a public disclosure to the market about a material event. The length (under 5,000 characters) and content structure confirm it is a news announcement, not a full report.
2008-09-09 Swedish
Regulatory Filings 2008
Regulatory Filings Classification · 95% confidence The document is a short press release dated September 1, 2008, announcing a specific business event: receiving European approval (CE mark) for a new product, Swemed Sense™. It includes quotes from management (Marketing Director and CEO) and provides company background information. This format is characteristic of an immediate business update or news release, not a comprehensive financial report (like 10-K or IR) or a formal regulatory filing like a proxy statement or earnings release. Since it is a general announcement of a significant business development (product approval and launch), it fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous, time-sensitive announcement that doesn't fit the more specific operational or financial report codes.
2008-09-01 English
Regulatory Filings 2008
Regulatory Filings Classification · 95% confidence The document is a press release dated September 1, 2008, announcing that the company (Vitrolife) has received European approval (CE mark) for a new product (Swemed Sense™ needle) and that production and initial delivery have commenced. This is a general corporate announcement regarding a new product launch and regulatory milestone, not a formal financial report (like 10-K, IR, ER) or a specific regulatory filing like insider trading (DIRS) or dividend announcement (DIV). Since it is a general announcement about a significant business event (new product approval/launch) that doesn't fit the other specific categories, it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory/corporate news releases that aren't earnings or capital structure focused. Given the content is a press release announcing a business development, RNS is the most appropriate fit among the provided options.
2008-09-01 Swedish
Regulatory Filings 2008
Regulatory Filings Classification · 95% confidence The document is a short press release dated August 28, 2008, announcing regulatory approval from Canadian authorities for the STEEN Solution™ study, which is key for future US/Canada sales approval. It details product information, study plans, and contact details. It is not a comprehensive annual report (10-K), an interim report (IR), a formal earnings release (ER), or a management discussion (MDA). Since it is a specific announcement regarding regulatory/product development news that doesn't fit the other specific categories (like DIRS, DIV, CAP, etc.), and it is a formal press release, it best fits the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory announcements not covered elsewhere. Given its nature as a press release announcing a regulatory milestone, RNS is the most appropriate fit.
2008-08-28 English
Legal Proceedings Report 2008
Legal Proceedings Report Classification · 99% confidence The document is a short press release dated August 28, 2008, announcing that Vitrolife has received approval from Canadian authorities to start a study with STEEN Solution™, which is intended to support future sales applications in the USA and Canada. It details product information, market position, and contact details. The document length is short (3689 characters) and functions as an immediate public announcement of a specific event (regulatory approval for a study). This fits the description of a general regulatory announcement or a press release that doesn't fit a specific financial report category. Since it is a specific, time-sensitive announcement that is not a formal financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, SHA, DIRS), the most appropriate general category is Regulatory Filings (RNS), as it serves as a general regulatory update/announcement.
2008-08-28 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.